Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV

AIDS. 2020 Jul 1;34(8):1258-1260. doi: 10.1097/QAD.0000000000002571.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-HIV Agents / therapeutic use
  • Asthma / complications
  • Betacoronavirus
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques
  • Coronavirus Infections / complications
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / therapy
  • DNA, Bacterial
  • Diagnosis, Differential
  • Emtricitabine / therapeutic use
  • Glucocorticoids / therapeutic use
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Lung / diagnostic imaging
  • Male
  • Middle Aged
  • Multiplex Polymerase Chain Reaction
  • Oxygen Inhalation Therapy
  • Pandemics
  • Pneumocystis carinii
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / diagnosis*
  • Pneumonia, Pneumocystis / drug therapy
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / therapy
  • Prednisolone / therapeutic use
  • RNA, Viral
  • Raltegravir Potassium / therapeutic use
  • Real-Time Polymerase Chain Reaction
  • SARS-CoV-2
  • Tenofovir / therapeutic use
  • Tomography, X-Ray Computed
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
  • Viral Load

Substances

  • Anti-Bacterial Agents
  • Anti-HIV Agents
  • DNA, Bacterial
  • Glucocorticoids
  • RNA, Viral
  • Raltegravir Potassium
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Tenofovir
  • Prednisolone
  • Emtricitabine